Kristen Bova Campbell

ORCID: 0000-0001-7729-6434
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • ECG Monitoring and Analysis
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Valve Diseases and Treatments
  • Viral Infections and Immunology Research
  • Cardiac Structural Anomalies and Repair
  • Poisoning and overdose treatments
  • Mechanical Circulatory Support Devices
  • AI-based Problem Solving and Planning
  • Ergonomics and Musculoskeletal Disorders
  • Voice and Speech Disorders
  • Musculoskeletal pain and rehabilitation
  • Cardiac tumors and thrombi
  • Health Sciences Research and Education
  • Occupational Health and Performance
  • Chemotherapy-related skin toxicity
  • Aortic Disease and Treatment Approaches
  • Cardiovascular Effects of Exercise
  • Cardiovascular Function and Risk Factors
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients

Duke Medical Center
2011-2023

Duke University Hospital
2011-2023

Maine Medical Center
2022

Campbell Collaboration
2020

The University of Adelaide
2019

Duke University
2016-2018

Duke University Health System
2007-2017

Indianapolis Zoo
2016

American College of Clinical Pharmacy
2016

University of North Carolina at Pembroke
2016

BackgroundDiabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM.ObjectiveThe purpose of this study was to compare AF in DM.MethodsWe performed a retrospective analysis 351 consecutive who underwent first-time ablation. Clinical included freedom from recurrent arrhythmia, symptom burden (Mayo Symptom Inventory score), cardiovascular all-cause...

10.1016/j.hroo.2020.04.006 article EN cc-by-nc-nd Heart Rhythm O2 2020-05-12

For decades, a precept was passed down by academic physicians to trainees and staff as guideline for inpatient care of patients with diabetes. That bit wisdom held that it is best “keep the patient little sweet.” The Diabetes Control Complications Trial1 U.K. Prospective Study2 showed ability intensified control reduce microvascular complications Despite increased risk hypoglycemia, these trials changed practice patterns in ambulatory settings favor intensification diabetes therapy. Among...

10.2337/diaclin.22.2.81 article EN Clinical Diabetes 2004-04-01

Study Objective To evaluate the impact of continuous-flow left ventricular assist device (LVAD) implantation on glycemic control in patients with type 2 diabetes mellitus and advanced chronic systolic heart failure. Design Retrospective medical record review. Setting Large academic tertiary quaternary care hospital. Patients Eighty-three adults failure who underwent a LVAD between July 1, 2008, June 30, 2013. Measurements Main Results Baseline demographic data laboratory values pertinent to...

10.1002/phar.1853 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2016-10-25

To assess whether obstructive sleep apnea (OSA) was associated with increased rotor burden among atrial fibrillation (AF) patients. We studied 33 consecutive patients who were scheduled for focal impulse and modulation (FIRM) ablation at our institution to describe the mapping, ablation, outcomes, without OSA. Patients underwent biatrial FIRM mapping in AF of stable rotors addition conventional lesion sets. Differences between groups tested student's t-tests Fisher's exact tests, as...

10.1093/europace/eux248 article EN EP Europace 2017-08-09

This document provides a framework for comprehensive educational competencies that the contributors see as essential heart rhythm providers, including physicians and allied professionals. does not take place of licensing examinations required providers. The is blueprint study assessment gaps in knowledge. road map knowledge, nearly 300 realms knowledge skill covering broad range clinical cardiac electrophysiology (CCEP) practice. list meant to be exhaustive, it expected an individual...

10.1016/j.hroo.2022.02.013 article EN cc-by-nc-nd Heart Rhythm O2 2022-04-01

Dofetilide, a class III antiarrhythmic agent, is prescribed for conversion to and maintenance of normal sinus rhythm in patients with persistent atrial fibrillation or flutter. Most antiarrhythmics have significant toxicities such as torsade de pointes, should be closely monitored while receiving therapy. However, we know no reports concerning management intentional overdose dofetilide that been published. We report the case 33‐year‐old man who was treated ingestion approximately 5 mg...

10.1592/phco.27.3.459 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2007-02-23

Cardiovascular implantable electronic device (CIED) infections have high mortality and morbidity. CIED secondary to gram-negative pathogens are rare, there few data regarding their treatment. We report a case of 60-year-old male who developed recurrent Salmonella enteritidis bacteremia leading infection nonsusceptibility ciprofloxacin.

10.1093/ofid/ofac668 article EN cc-by-nc-nd Open Forum Infectious Diseases 2022-12-01

The optimal way of pacing in patients with an indication for and concomitant first-degree atrioventricular (AV)-block is not known, consequently, firm guidelines on this topic are lacking. This study explored the current pacemaker programming pattern AV-block who have a dual chamber without cardiac resynchronization.The was retrospective chart review conducted at Duke University Hospital. Patients receiving due to sinus node dysfunction coexistent were studied. Baseline demographics...

10.1002/hsr2.39 article EN cc-by Health Science Reports 2018-05-09
Coming Soon ...